Proactive Investors - Run By Investors For Investors

Kromek's Dr Arnab Basu hails use of security devices during Trump visit

Dr Arnab Basu, chief executive of Kromek Group PLC (LON:KMK) tells Proactive's Andrew Scott the use of their radiation technology at high profile political events - such as US President Donald Trump's visit to Brussels - validates their business model.

Kromek was informed that the deployment was successful and its radiation detection systems performed well and met the desired high standards for accuracy and efficiency.

 
Meet Alliance Pharma PLC, IXICO PLC, Benchmark Holdings PLC, Clinigen Group PLC and Shield Therapeutics PLC at our event, London , 24 January 2019. Register here »
View full KMK profile View Profile

Kromek Group PLC Timeline

© Proactive Investors 2018

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use